Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival

Chest

Volumn 152, Issue 3, 2017, Pages 587-597

  Soneji, Samir ^a,b,c   Tanner, Nichole T ^e,f   Silvestri, Gerard A ^e   Lathan, Christopher S ^d   Black, William ^a,b,c  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c NORRIS COTTON CANCER CENTER   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

disparities; lung cancer; surgical oncology

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BENIGN NEOPLASM; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CAUCASIAN; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; EARLY DIAGNOSIS; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PACIFIC ISLANDER; POPULATION RESEARCH; PRIORITY JOURNAL; RACISM; SMOKING; STANDARDIZATION; SURVIVAL TIME; VERY ELDERLY; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; HEALTH DISPARITY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 85029005388     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2017.03.059     Document Type: Article

References (72)

1. Howlader, N., Noone, A., Krapcho, M., et al. SEER cancer statistics review, 1975-2012. 2015, National Cancer Institute, Bethesda, MD.
2. Greenwald, H.P., Polissar, N.L., Borgatta, E.F., McCorkle, R., Goodman, G., Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health 88:11 (1998), 1681–1684.
3. Bach, P.B., Cramer, L.D., Warren, J.L., Begg, C.B., Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:16 (1999), 1198–1205.
4. Wisnivesky, J.P., McGinn, T., Henschke, C., Hebert, P., Iannuzzi, M.C., Halm, E.A., Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 171:10 (2005), 1158–1163.
5. Lathan, C.S., Neville, B.A., Earle, C.C., Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J Clin Oncol 26:26 (2008), 4347–4352.
6. Hardy, D., Liu, C.-C., Xia, R., et al. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer 115:10 (2009), 2199–2211.
7. Cykert, S., Dilworth-Anderson, P., Monroe, M.H., et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 303:23 (2010), 2368–2376.
8. Shields, T.W., Surgical therapy for carcinoma of the lung. Clin Chest Med 14:1 (1993), 121–147.
9. Ettinger, D.S., Cox, J.D., Ginsberg, R.J., et al. NCCN non-small-cell lung cancer practice guidelines. J Natl Compr Canc Netw 10:11 suppl (1996), 81–111.
10. Lam, W.K., Management of non-small cell lung cancer according to staging—an update. Respirology 3:1 (1998), 51–54.
11. Colby, S., Ortman, J., Projections of the size and composition of the U.S. population: 2014 to 2060. 2014, US Census Bureau, Washington, DC.
12. Fine, J.P., Gray, R.J., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:446 (1999), 496–509.
13. Scrucca, L., Santucci, A., Aversa, F., Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transpl 40:4 (2007), 381–387.
14. Scrucca, L., Santucci, A., Aversa, F., Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transpl 45:9 (2010), 1388–1395.
15. Balduyck, B., Hendriks, J., Lauwers, P., Van Schil, P., Quality of life evolution after lung cancer surgery: a prospective study in 100 patients. Lung Cancer 56:3 (2007), 423–431.
16. Yan, T.D., Black, D., Bannon, P.G., McCaughan, B.C., Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non–small-cell lung cancer. J Clin Oncol 27:15 (2009), 2553–2562.
17. Kates, M., Swanson, S., Wisnivesky, J.P., Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer <=1 cm in size: a review of SEER data. Chest 139:3 (2011), 491–496.
18. Paoletti, L., Pastis, N.J., Denlinger, C.E., Silvestri, G.A., A decade of advances in treatment of early-stage lung cancer. Clin Chest Med 32:4 (2011), 827–838.
19. Harrison, M.A., Hegarty, S.E., Keith, S.W., Cowan, S.W., Evans, N.R. III, Racial disparity in in-hospital mortality after lobectomy for lung cancer. Am J Surg 209:4 (2015), 652–658.
20. Bach, P.B., Cramer, L.D., Schrag, D., Downey, R.J., Gelfand, S.E., Begg, C.B., The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 345:3 (2001), 181–188.
21. Lucas, F.L., Stukel, T.A., Morris, A.M., Siewers, A.E., Birkmeyer, J.D., Race and surgical mortality in the United States. Ann Surg 243:2 (2006), 281–286.
22. Dimick, J., Ruhter, J., Sarrazin, M.V., Birkmeyer, J.D., Black patients more likely than whites to undergo surgery at low-quality hospitals in segregated regions. Health Aff (Millwood) 32:6 (2013), 1046–1053.
23. Morris, A.M., Rhoads, K.F., Stain, S.C., Birkmeyer, J.D., Understanding racial disparities in cancer treatment and outcomes. J Am Coll Surg 211:1 (2010), 105–113.
24. Patel, M.I., Wang, A., Kapphahn, K., et al. Racial and ethnic variations in lung cancer incidence and mortality: results from the Women's Health Initiative. J Clin Oncol 34:4 (2016 Feb 1), 360–368.
25. Siegel, R.L., Fedewa, S.A., Miller, K.D., et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin 65:6 (2015), 457–480.
26. Blackwell, D., Lucas, J., Clarke, T., Summary health statistics for U.S. adults: national health interview survey, 2012. 2014, Centers for Disease Control and Prevention, National Center for Health Statistics, Atlanta, GA.
27. Ou, S.-H.I., Ziogas, A., Zell, J.A., Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol 4:9 (2009), 1083–1093.
28. Thun, M.J., Hannan, L.M., Adams-Campbell, L.L., et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med, 5(9), 2008, e185.
29. Rudin, C.M., Avila-Tang, E., Harris, C.C., et al. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res 15:18 (2009), 5646–5661.
30. Sun, S., Schiller, J.H., Gazdar, A.F., Lung cancer in never smokers—a different disease. Nat Rev Cancer 7:10 (2007), 778–790.
31. Helland, Å., Skaug, H.M., Kleinberg, L., et al. EGFR gene alterations in a Norwegian cohort of patients with lung cancer selected for surgery. J Thorac Oncol 6:5 (2011), 947–950.
32. Kadota, K., Sima, C.S., Arcila, M.E., et al. KRAS mutation is a significant prognostic factor in early-stage lung adenocarcinoma. Am J Surg Pathol 40:12 (2016), 1579–1590.
33. Smedley, B.D., Stith, A.Y., Nelson, A.R., (eds.) Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care, 2003, National Academies Press, Washington, DC.
34. Williams, D.R., Sternthal, M., Understanding Racial-ethnic disparities in health sociological contributions. J Health Soc Behav 51:1 suppl (2010), S15–S27.
35. Williams, D.R., Mohammed, S.A., Leavell, J., Collins, C., Race, socioeconomic status, and health: Complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci 1186:1 (2010), 69–101.
36. Williams, D., Mohammed, S.A., Racism and health I: pathways and scientific evidence. Am Behav Sci 57:8 (2013), 1152–1173.
37. Williams, D.R., Wyatt, R., Racial bias in health care and health: challenges and opportunities. JAMA 314:6 (2015), 555–556.
38. Lewis, T.T., Everson-Rose, S.A., Powell, L.H., et al. Chronic exposure to everyday discrimination and coronary artery calcification in African-American women: the SWAN Heart Study. Psychosom Med 68:3 (2006), 362–368.
39. Brondolo, E., Brady, N., Thompson, S., et al. Perceived racism and negative affect: analyses of trait and state measures of affect in a community sample. J Soc Clin Psychol 27:2 (2008), 150–173.
40. Sawyer, P.J., Major, B., Casad, B.J., Townsend, S.S.M., Mendes, W.B., Discrimination and the stress response: psychological and physiological consequences of anticipating prejudice in interethnic interactions. Am J Public Health 102:5 (2012), 1020–1026.
41. Shi, L., Chen, C.-C., Nie, X., Zhu, J., Hu, R., Racial and socioeconomic disparities in access to primary care among people with chronic conditions. J Am Board Fam Med 27:2 (2014), 189–198.
42. Smith J, Medalia C. Health insurance coverage in the United States: 2014. Washington DC: US Census Bureau; 2015.
43. Bach, P.B., Pham, H.H., Schrag, D., Tate, R.C., Hargraves, J.L., Primary care physicians who treat blacks and whites. N Engl J Med 351:6 (2004), 575–584.
44. Jha, A.K., Orav, E.J., Li, Z., Epstein, A.M., Concentration and quality of hospitals that care for elderly black patients. Arch Intern Med 167:11 (2007), 1177–1182.
45. Cook, N.L., Hicks, L.S., O'Malley, A.J., Keegan, T., Guadagnoli, E., Landon, B.E., Access to specialty care and medical services in community health centers. Health Aff (Milwood) 26:5 (2007), 1459–1468.
46. Esnaola, N.F., Ford, M.E., Racial differences and disparities in cancer care and outcomes: where's the rub?. Surg Oncol Clin N Am 21:3 (2012), 417–1437 viii.
47. Epstein, A.J., Gray, B.H., Schlesinger, M., Racial and ethnic differences in the use of high-volume hospitals and surgeons. Arch Surg 145:2 (2010), 179–186.
48. Williams, C.D., Salama, J.K., Moghanaki, D., Karas, T.Z., Kelley, M.J., Impact of race on treatment and survival among U.S. veterans with early-stage lung cancer. J Thorac Oncol 11:10 (2016), 1672–1681.
49. Tanner, N.T., Gebregziabher, M., Hughes Halbert, C., Payne, E., Egede, L.E., Silvestri, G.A., Racial differences in outcomes within the National Lung Screening Trial. Implications for widespread implementation. Am J Respir Crit Care Med 192:2 (2015), 200–208.
50. Williams, C.D., Stechuchak, K.M., Zullig, L.L., Provenzale, D., Kelley, M.J., Influence of comorbidity on racial differences in receipt of surgery among US Veterans with early-stage non–small-cell lung cancer. J Clin Oncol 31:4 (2013), 475–481.
51. Landrum, M.B., Keating, N.L., Lamont, E.B., Bozeman, S.R., McNeil, B.J., Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration. Cancer 118:13 (2012), 3345–3355.
52. Colla, C.H., Morden, N.E., Sequist, T.D., Schpero, W.L., Rosenthal, M.B., Choosing wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med 30:2 (2015), 221–228.
53. Margolis, M.L., Christie, J.D., Silvestri, G.A., Kaiser, L., Santiago, S., Hansen-Flaschen, J., Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med 139:7 (2003), 558–563.
54. Kumar, P., Gareen, I.F., Lathan, C., et al. Racial differences in tobacco cessation and treatment usage after lung screening: an examination of the National Lung Screening Trial. The Oncologist 21:1 (2016), 40–49.
55. Bacio, G.A., Guzman, I.Y., Shapiro, J.R., Ray, L.A., Differences in quit attempts between non-hispanic black and white daily smokers: the role of smoking motives. Addict Behav 39:12 (2014), 1769–1772.
56. Kulak, J.A., Cornelius, M.E., Fong, G.T., Giovino, G.A., Differences in quit attempts and cigarette smoking abstinence between whites and African Americans in the United States: literature review and results from the International Tobacco Control US Survey. Nicotine Tob Res 18:suppl 1 (2016), S79–S87.
57. Gandhi, K.K., Foulds, J., Steinberg, M.B., Lu, S.-E., Williams, J.M., Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract 63:3 (2009), 360–367.
58. Okuyemi, K.S., Ahluwalia, J.S., Ebersole-Robinson, M., Catley, D., Mayo, M.S., Resnicow, K., Does menthol attenuate the effect of bupropion among African American smokers?. Addiction 98:10 (2003), 1387–1393.
59. Levinson, A.H., Pérez-Stable, E.J., Espinoza, P., Flores, E.T., Byers, T.E., Latinos report less use of pharmaceutical aids when trying to quit smoking. Am J Prev Med 26:2 (2004), 105–111.
60. Levinson, A.H., Borrayo, E.A., Espinoza, P., Flores, E.T., Pérez-Stable, E.J., An exploration of Latino smokers and the use of pharmaceutical aids. Am J Prev Med 31:2 (2006), 167–171.
61. German, R.R., Fink, A.K., Heron, M., et al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol 35:2 (2011), 126–131.
62. National Cancer Institute. Surveillance, Epidemiology and End Results Program. Number of persons by race and hispanic ethnicity (2010 census data). http://seer.cancer.gov/registries/data.html. Accessed January 22, 2016.
63. Humes, K., Jones, N., Ramirez, R., Overview of race and Hispanic origin: 2010. 2011, US Census Bureau, Suitland, MD.
64. Mackun, P., Wilson, S., Population distribution and change: 2000 to 2010. 2011, U.S. Census Bureau, Suitland, MD.
65. Liao, Y., Greenlund, K.J., Croft, J.B., Keenan, N.L., Giles, W.H., Factors explaining excess stroke prevalence in the US stroke belt. Stroke 40:10 (2009), 3336–3341.
66. Barker, L.E., Kirtland, K.A., Gregg, E.W., Geiss, L.S., Thompson, T.J., Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med 40:4 (2011), 434–439.
67. Leidner, R.S., Fu, P., Clifford, B., et al. Genetic abnormalities of the EGFR pathway in African American patients with non–small-cell lung cancer. J Clin Oncol 27:33 (2009), 5620–5626.
68. Bollig-Fischer, A., Chen, W., Gadgeel, S.M., et al. Racial diversity of actionable mutations in non-small cell lung cancer. J Thorac Oncol 10:2 (2015), 250–255.
69. Araujo, L.H., Timmers, C., Bell, E.H., et al. Genomic characterization of non-small-cell lung cancer in African Americans by targeted massively parallel sequencing. J Clin Oncol 33:17 (2015), 1966–1973.
70. Campbell JD, Lathan C, Sholl L, et al. Comparison of prevalence and types of mutations in lung cancers among black and white populations [published online ahead of print January 19, 2017]. JAMA Oncol. http://dx.doi.org/10.1001/jamaoncol.2016.6108.
71. Spratt, D.E., Chan, T., Waldron, L., et al. Racial/ethnic disparities in genomic sequencing. JAMA Oncol 2:8 (2016), 1070–1074.
72. Li, T., Kung, H.-J., Mack, P.C., Gandara, D.R., Genotyping and genomic profiling of non–small-cell lung cancer: implications for current and future therapies. J Clin Oncol 31:8 (2013), 1039–1049.